1,181
edits
Changes
Jump to navigation
Jump to search
Critics of the current patent system also believe it does not incentivize enough research and development for drugs that benefit society as a whole. [http://articles.economictimes.indiatimes.com/2012-05-28/news/31877151_1_drug-prices-intellectual-property-innovation (Economic Times)]
→Criticisms
'''Right to Exclude''': The current patent system allows companies to file for the right to exclude if they have a novel, non-obvious invention. The right to exclude creates a temporary monopoly for a certain product, creating the potential for higher prices for consumers. Daraprim, a drug produced by Turing Pharmaceuticals, was at one point in time priced at $750 per pill for commercial sale.The CEO OF Turing Pharmaceuticals, Martin Shkreli, led the charge to such an exorbitant price hike, earning himself the title of "Most Hated Man in America." <ref name= "BBC" />
==Patent Pools==
